نتایج جستجو برای: non alcoholic steatohepatitis

تعداد نتایج: 1341204  

Journal: :Annals of hepatology 2012
Gesira Florentino Helma P Cotrim André Florentino Consuelo Padilha Manoel Medeiros-Neto Gerson Bragagnol Paulo Schwingel

Non-alcoholic fatty liver disease (NAFLD) represents a clinical condition that may progress from steatosis to steatohepatitis, cirrhosis and hepatocellular carcinoma. There are not enough information about the relationship between menopause and NAFLD, and this study evaluated the relevance of this liver disease in menopausal women (MPW), and the relationship between hormone replacement therapy ...

Journal: :Diabetology & Metabolic Syndrome 2021

Abstract Background Dipeptidyl peptidase 4 (DPP4) is a serine exopeptidase able to inactivate various oligopeptides, and also hepatokine. Hepatocyte-specific overexpression of DPP4 associated with hepatic insulin resistance liver steatosis. Method We examined whether weekly inhibitor omarigliptin (OMG) can improve function as well levels inflammation in type 2 diabetic patients non-alcoholic fa...

2012
Shaminie Athinarayanan Wanqing Liu

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in the world. An important implication of this disease is the progression of the disease to a more complicated condition called non-alcoholic steatohepatitis (NASH) and the wide variety of clinical presentations. Over the past 5 years, remarkable progresses have been made in understanding the genetic basis for th...

2018

Submit Manuscript | http://medcraveonline.com Abbreviations: IM: Intestinal Metaplasia; EAC: Esophageal Adenocarcinoma; HGD: High Grade Dysplasia; LGD: Low Grade Dysplasia; GAVE: Gastric Astral Vascular Ectasia; GERD: Gastroesophageal Acid Reflux Disease; PPI: Proton Pump Inhibitor; HCC: Hepatocellular Carcinoma; ASGE: American Society of Gastrointestinal Endoscopy; BE: Barrett’s Esophagus; EGD...

2014
Vijaya Juturu

MZ: Meso-Zeaxanthin; L: Lutein; RZ: RR-Zeaxanthin; AMD: Age-related Macular Degeneration; MD: Macular Degeneration; NAFL: Non-Alcoholic Fatty Liver; NASH: Nonalcoholic Steatohepatitis; DPPH: Diphenyl-2-Picrylhydrazyl; ABTS: 2, 2’-Azino-Bis (3-Ethylbenzothiazoline-6-Sulfonic acid); GST: Glutathione-S-Transferase; UDPGT: Uridine Diphosphate Glucuronyl Transferase; SGOT: Serum glutamic oxaloacetic...

2014
Jérémie Gautheron Mihael Vucur Florian Reisinger David Vargas Cardenas Christoph Roderburg Christiane Koppe Karina Kreggenwinkel Anne Theres Schneider Matthias Bartneck Ulf Peter Neumann Ali Canbay Helen Louise Reeves Mark Luedde Frank Tacke Christian Trautwein Mathias Heikenwalder Tom Luedde

Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disease in Western countries and often progresses to non-alcoholic steatohepatitis (NASH) leading ultimately to liver fibrosis and liver cancer. The occurrence of hepatocyte cell death-so far characterized as hepatocyte apoptosis-represents a fundamental step from benign steatosis toward progressive steatohepatitis. In c...

2014
Surapaneni Krishna Mohan Mallika Jainu

Background: Non-alcoholic steatohepatitis (NASH) is an emerging disease belonging to the non-alcoholic fatty liver disease (NAFLD) spectrum, which may progress to fibrosis and thereby to cirrhosis of the liver. Currently, no definitive and effective treatment strategies have been identified to treat NASH. Objective: To study the effect of pioglitazone, quercetin, and hydroxy citric acid on lipi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید